Chimeric nanoparticles for targeting mitochondria in cancer cells

Mitochondrial dysfunction is implicated in myriad diseases, including cancer. Subsequently, targeting mitochondrial DNA (mt-DNA) in cancer cells has emerged as an unorthodox strategy for anti-cancer therapy. However, approaches targeting only one component of the mitochondrial “central dogma” can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajpai, Aman, Desai, Nakshi Nayan, Pandey, Shalini, Shukla, Chinmayee, Datta, Bhaskar, Basu, Sudipta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419202/
https://www.ncbi.nlm.nih.gov/pubmed/36131756
http://dx.doi.org/10.1039/d1na00644d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419202/
https://www.ncbi.nlm.nih.gov/pubmed/36131756
http://dx.doi.org/10.1039/d1na00644d

Ejemplares similares